Stemline Therapeutics, Inc.
H‑1B Sponsor Verified
Yes. Stemline Therapeutics, Inc. filed 12 H-1B labor condition applications (LCAs) with the U.S. Department of Labor from 2021–2026, including 2 so far in 2026. The average H-1B salary is $195,523 and the most sponsored role is Avp, Commercial Excellence Analytics.
Source: U.S. Department of Labor LCA disclosure data. Most recent filing on record: Jun 12, 2026.
LinkedIn ↗Latest Year Filings
2
In 2026
↗ Filter by year
Total H‑1B Filings
12
Since 2020
↗ View records
Avg Annual Salary
$195,523
All years combined
↗ View chart
Top Role
Avp, Commercial Excellence Analyti…
↗ Click to filter
Filing trend
H‑1B filings by year for Stemline Therapeutics, Inc.
| Year | LCA filings | Avg salary |
|---|---|---|
| 2026 | 2 | $173,772 |
| 2025 | 3 | $275,667 |
| 2024 | 2 | $146,526 |
| 2023 | 1 | $175,000 |
| 2022 | 3 | $201,226 |
| 2021 | 1 | $100,000 |
Click a bar to filter records
Yearly filings & average salary · swipe to explore
SponsorStats AI
Summary